Indivior PLC Ordinary Shares (INDV) had the highest return between August 5, 2022 and January 3, 2023 by a US stock with a market cap of $300M+, returning 476.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Indivior PLC Ordinary Shares (INDV) | 8/5/2022 - 1/3/2023 | 476.92% |
Summit Therapeutics (SMMT) | 8/5/2022 - 1/3/2023 | 416% |
Immunovant (IMVT) | 8/5/2022 - 1/3/2023 | 330.05% |
Terns Pharmaceuticals (TERN) | 8/5/2022 - 1/3/2023 | 312.21% |
Verona Pharma PLC ADR (VRNA) | 8/5/2022 - 1/3/2023 | 301.31% |
Madrigal Pharmaceuticals (MDGL) | 8/5/2022 - 1/3/2023 | 289.39% |
Akero Therapeutics (AKRO) | 8/5/2022 - 1/3/2023 | 281.87% |
Ardelyx (ARDX) | 8/5/2022 - 1/3/2023 | 257.33% |
Studio City International (MSC) | 8/5/2022 - 1/3/2023 | 251.89% |
Astria Therapeutics (ATXS) | 8/5/2022 - 1/3/2023 | 236.24% |
89bio (ETNB) | 8/5/2022 - 1/3/2023 | 235.29% |
Enliven Therapeutics (ELVN) | 8/5/2022 - 1/3/2023 | 225.62% |
Viking Therapeutics (VKTX) | 8/5/2022 - 1/3/2023 | 167.92% |
Waterdrop Inc ADR (WDH) | 8/5/2022 - 1/3/2023 | 161.28% |
Wave Life Sciences (WVE) | 8/5/2022 - 1/3/2023 | 158.33% |
YPF Sociedad Anonima (YPF) | 8/5/2022 - 1/3/2023 | 141.94% |
Melco Resorts & Entertainment (MLCO) | 8/5/2022 - 1/3/2023 | 137.23% |
Biohaven Pharmaceutical (BHVN) | 8/5/2022 - 1/3/2023 | 125% |
Weatherford International (WFRD) | 8/5/2022 - 1/3/2023 | 124.18% |
Harrow Health (HROW) | 8/5/2022 - 1/3/2023 | 123.6% |
Turkcell Iletisim Hizmetleri AS (TKC) | 8/5/2022 - 1/3/2023 | 120.51% |
Rayonier Advanced Materials (RYAM) | 8/5/2022 - 1/3/2023 | 115.24% |
MoonLake Immunotherapeutics (MLTX) | 8/5/2022 - 1/3/2023 | 113.66% |
Power Solutions International, Inc Common Stock (PSIX) | 8/5/2022 - 1/3/2023 | 111.97% |
Viridian Therapeutics (VRDN) | 8/5/2022 - 1/3/2023 | 111.42% |
